Impaired proliferation of non-parenchymal cells participates in an impairment of liver regeneration in db/db mice

Exp Mol Pathol. 2005 Aug;79(1):51-8. doi: 10.1016/j.yexmp.2005.02.002. Epub 2005 Apr 7.

Abstract

In this study, we examined the possibility that impaired proliferation of non-parenchymal cells affects in an impairment of liver regeneration in db/db mice, which are congenitally deficient in receptors for leptin. Liver regeneration after a two thirds partial hepatectomy (2/3 PH) was impaired in 10-week-old female db/db mice. The proliferation of both hepatocytes and non-parenchymal cells estimated from a bromodeoxyuridine (BrdU) labeling index was suppressed, and the protein expression of vascular endothelial growth factor was blocked in db/db mice. Although the extent of fatty change and the level of epidermal growth factor receptor protein expression in the liver were improved in 5-week-old db/db mice, the regeneration of liver was impaired after 2/3 PH in both 5- and 10-week-old db/db mice. These results suggested that suppressed proliferation of non-parenchymal cells contributes to the impairment of liver regeneration in db/db mice. As leptin has also the angiogenic effect, the angiogenic inhibitor FR-118487 was administered to ICR mice to examine liver regeneration after 2/3 PH, and the rate of regeneration was affected. In conclusion, it is suggested that the suppressed proliferation of non-parenchymal cells contributes to the impairment of liver regeneration probably through a disrupted angiogenesis in db/db mice.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Blotting, Western
  • Cell Proliferation* / drug effects
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • ErbB Receptors / biosynthesis
  • Fatty Liver / metabolism*
  • Female
  • Hepatectomy
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Liver / cytology*
  • Liver / drug effects
  • Liver Regeneration / drug effects
  • Liver Regeneration / physiology*
  • Mice
  • Mice, Mutant Strains
  • Receptors, Cell Surface / deficiency*
  • Receptors, Leptin
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spiro Compounds / pharmacology
  • Vascular Endothelial Growth Factor A / biosynthesis

Substances

  • Angiogenesis Inhibitors
  • FR 118487
  • Receptors, Cell Surface
  • Receptors, Leptin
  • Spiro Compounds
  • Vascular Endothelial Growth Factor A
  • ErbB Receptors